Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:58 UTC |
---|
HMDB ID | HMDB0015403 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Lumiracoxib |
---|
Description | Lumiracoxib, also known as COX 189 or prexige, belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group. Lumiracoxib is a drug which is used for the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults. Lumiracoxib is an extremely weak basic (essentially neutral) compound (based on its pKa). In humans, lumiracoxib is involved in lumiracoxib action pathway. |
---|
Structure | CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1 InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20) |
---|
Synonyms | Value | Source |
---|
2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid | ChEBI | COX 189 | ChEBI | COX-189 | ChEBI | COX189 | ChEBI | Lumiracoxibum | ChEBI | Prexige | ChEBI | 2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetate | Generator |
|
---|
Chemical Formula | C15H13ClFNO2 |
---|
Average Molecular Weight | 293.721 |
---|
Monoisotopic Molecular Weight | 293.061884577 |
---|
IUPAC Name | 2-{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid |
---|
Traditional Name | lumiracoxib |
---|
CAS Registry Number | 220991-20-8 |
---|
SMILES | CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1 |
---|
InChI Identifier | InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20) |
---|
InChI Key | KHPKQFYUPIUARC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Toluenes |
---|
Direct Parent | Aminotoluenes |
---|
Alternative Parents | |
---|
Substituents | - Aminotoluene
- Aniline or substituted anilines
- Chlorobenzene
- Fluorobenzene
- Halobenzene
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Amino acid or derivatives
- Amino acid
- Carboxylic acid derivative
- Secondary amine
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Amine
- Organohalogen compound
- Organochloride
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0055 g/L | Not Available | LogP | 3.9 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Lumiracoxib,1TMS,isomer #1 | CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O[Si](C)(C)C)=C1 | 2266.5 | Semi standard non polar | 33892256 | Lumiracoxib,1TMS,isomer #2 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C)C(CC(=O)O)=C1 | 2276.7 | Semi standard non polar | 33892256 | Lumiracoxib,2TMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2253.8 | Semi standard non polar | 33892256 | Lumiracoxib,2TMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2227.9 | Standard non polar | 33892256 | Lumiracoxib,2TMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2624.5 | Standard polar | 33892256 | Lumiracoxib,1TBDMS,isomer #1 | CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2518.4 | Semi standard non polar | 33892256 | Lumiracoxib,1TBDMS,isomer #2 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O)=C1 | 2509.2 | Semi standard non polar | 33892256 | Lumiracoxib,2TBDMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2733.6 | Semi standard non polar | 33892256 | Lumiracoxib,2TBDMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2629.8 | Standard non polar | 33892256 | Lumiracoxib,2TBDMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=CC=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2848.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lumiracoxib GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-2290000000-3dc98edbc540838a7548 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lumiracoxib GC-MS (1 TMS) - 70eV, Positive | splash10-00g1-9152000000-5997fd55576c52d1c4b4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lumiracoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 10V, Positive-QTOF | splash10-002f-0090000000-df6ae4f2e3e5251bab0d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 20V, Positive-QTOF | splash10-0002-0090000000-4e4dbea4d96e0566d989 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 40V, Positive-QTOF | splash10-001j-2190000000-a2a86d3a4122bc5a8756 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 10V, Negative-QTOF | splash10-0007-0090000000-e36154890c850cdb9918 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 20V, Negative-QTOF | splash10-0007-0090000000-554e0c5cc5da60a0d0b4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 40V, Negative-QTOF | splash10-05cv-3390000000-1fff2d7114e1511e7bb0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 10V, Positive-QTOF | splash10-0059-0090000000-15adaa3f8cb7a5dad42c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 20V, Positive-QTOF | splash10-000t-0090000000-954aa7c9b32169c17166 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 40V, Positive-QTOF | splash10-0a5a-0970000000-6662a5b1b7750d52f2c0 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 10V, Negative-QTOF | splash10-0006-0090000000-57cb6b0c2531295b071d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 20V, Negative-QTOF | splash10-00e9-2090000000-6ff6b3cb100db6c9f325 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lumiracoxib 40V, Negative-QTOF | splash10-001i-9050000000-93dedc8134cc64db3e8d | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|